Compare Intuitive Surgical, Inc. (ISRG) vs Rocket Companies Inc. Class A Common Stock (RKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Rocket Companies Inc. Class A Common Stock — how do they compare? Intuitive Surgical, Inc. trades at $422.44 (market cap $148.46B), while Rocket Companies Inc. Class A Common Stock trades at $10.72 (market cap $29.82B). The key difference: Intuitive Surgical, Inc. is far larger — about 5× Rocket Companies Inc. Class A Common Stock's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Rocket Companies Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Rocket Companies Inc. Class A Common Stock for 0 Days on average.
| ISRG | RKT | |
|---|---|---|
Market Cap | $148.46B | $29.82B |
Volume | 1,914,576 | 46,995,062 |
Sector | Health | Financials |
52-Week High | $592.85 | $23.44 |
52-Week Low | $332.02 | $10.53 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $143.25B | $59.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $422.06, down 1.3% on the day, but maintains strong fundamentals with consistent earnings beats and robust revenue growth from $6.2B in 2022 to $10.1B in 2025. The stock shows bullish technical signals with support at $414 and resistance at $431, while analyst consensus remains strongly positive with a $480.78 price target. Recent expansion into India and Japan helps offset China weakness, with da Vinci 5 upgrades driving recurring revenue streams.
ISRG presents a compelling growth opportunity with market leadership in robotic surgery and expanding international presence, though elevated valuation multiples (P/E 48.4) and competitive pressures warrant caution. The 70% buy rating from analysts suggests significant upside potential, but investors should monitor procedure growth rates and macroeconomic pressures affecting healthcare spending.
Rocket Companies (RKT) trades at $10.83, down 0.37% on the day, with a neutral technical signal and mixed earnings history. The stock is near its 52-week low amid a challenging mortgage market. Recent financials show a net loss of $68 million in 2025 but project a return to profitability in 2026. Analyst consensus is a 'Buy' with a $16.88 price target, though sentiment is tempered by high interest rates and housing market pressures.
Outlook: RKT offers potential upside from current depressed levels if mortgage demand recovers, but faces significant headwinds from persistent high rates and weak housing activity. Risks include competitive pressures and regulatory scrutiny, while opportunities lie in market share gains and cost management improvements. Investors should weigh the cyclical recovery potential against near-term macroeconomic challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Rocket Companies Inc. Class A Common Stock
Rocket Companies, Inc. operates a homeownership platform spanning mortgage origination and servicing, real estate, title and closing, and personal finance, with flagship brands including Rocket Mortgage, Rocket Close, Rocket Money, Rocket Loans, and Redfin.
Read more on RKT →
